
Procter & Gamble (P&G) faces challenges despite beating recent earnings, with softening volume in key segments and cautious fiscal 2026 guidance amid tariff and commodity pressures. Its valuation is high relative to growth risks, trading at a PE of 22 with modest yield and lagging market performance. In contrast, Colgate-Palmolive shows robust momentum, posting four straight earnings beats, accelerating cash flow, and strong international volume growth, especially in emerging markets. Colgate's solid margins and Dividend Aristocrat status support its resilience, making it a more attractive defensive stock option compared to the crowded P&G trade.